239 related articles for article (PubMed ID: 14692516)
1. Dendritic cells and their potential therapeutic role in haematological malignancy.
Kaminski ER; Goddard RV; Prentice AG
Leuk Lymphoma; 2003 Oct; 44(10):1657-66. PubMed ID: 14692516
[TBL] [Abstract][Full Text] [Related]
2. New approaches in the immunotherapy of haematological malignancies.
Costello RT; Rey J; Fauriat C; Gastaut JA; Olive D
Eur J Haematol; 2003 May; 70(5):333-45. PubMed ID: 12694173
[TBL] [Abstract][Full Text] [Related]
3. Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies.
Hutten T; Thordardottir S; Hobo W; Hübel J; van der Waart AB; Cany J; Dolstra H; Hangalapura BN
J Immunother; 2014 Jun; 37(5):267-77. PubMed ID: 24810638
[TBL] [Abstract][Full Text] [Related]
4. The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.
López M; Aguilera R; Pérez C; Mendoza-Naranjo A; Pereda C; Ramirez M; Ferrada C; Aguillón JC; Salazar-Onfray F
Immunobiology; 2006; 211(1-2):127-36. PubMed ID: 16446177
[TBL] [Abstract][Full Text] [Related]
5. Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumors.
Osada T; Nagaoka K; Takahara M; Yang XY; Liu CX; Guo H; Roy Choudhury K; Hobeika A; Hartman Z; Morse MA; Lyerly HK
J Immunother; 2015 May; 38(4):155-64. PubMed ID: 25839441
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of hematological malignancies using dendritic cells.
Van de Velde AL; Berneman ZN; Van Tendeloo VF
Bull Cancer; 2008 Mar; 95(3):320-6. PubMed ID: 18390412
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cell-based cancer immunotherapy: potential for treatment of colorectal cancer?
Chen W; Rains N; Young D; Stubbs RS
J Gastroenterol Hepatol; 2000 Jul; 15(7):698-705. PubMed ID: 10937673
[TBL] [Abstract][Full Text] [Related]
8. Review: the application of dendritic cell-derived exosomes in tumour immunotherapy.
Quah B; O'Neill HC
Cancer Biother Radiopharm; 2000 Apr; 15(2):185-94. PubMed ID: 10803324
[TBL] [Abstract][Full Text] [Related]
9. Specific immunotherapy of cancer in elderly patients.
Matzku S; Zöller M
Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell-based vaccines and therapies for cancer.
Tatsumi T; Storkus WJ
Expert Opin Biol Ther; 2002 Dec; 2(8):919-28. PubMed ID: 12517270
[TBL] [Abstract][Full Text] [Related]
11. Dendritic cell based vaccines: progress in immunotherapy studies for prostate cancer.
Ragde H; Cavanagh WA; Tjoa BA
J Urol; 2004 Dec; 172(6 Pt 2):2532-8. PubMed ID: 15538202
[TBL] [Abstract][Full Text] [Related]
12. From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy.
Dullaers M; Thielemans K
J Gene Med; 2006 Jan; 8(1):3-17. PubMed ID: 16288497
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells.
Yasuda T; Kamigaki T; Nakamura T; Imanishi T; Hayashi S; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Oncol Rep; 2006 Dec; 16(6):1317-24. PubMed ID: 17089056
[TBL] [Abstract][Full Text] [Related]
14. Anti-cancer vaccine therapy for hematologic malignancies: An evolving era.
Nahas MR; Rosenblatt J; Lazarus HM; Avigan D
Blood Rev; 2018 Jul; 32(4):312-325. PubMed ID: 29475779
[TBL] [Abstract][Full Text] [Related]
15. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cell immunotherapy for urological cancers using cryopreserved allogeneic tumour lysate-pulsed cells: a phase I/II study.
Pandha HS; John RJ; Hutchinson J; James N; Whelan M; Corbishley C; Dalgleish AG
BJU Int; 2004 Aug; 94(3):412-8. PubMed ID: 15291878
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-based immunotherapy for the treatment of hematological malignancies.
Büchler T; Michalek J; Kovarova L; Musilova R; Hajek R
Hematology; 2003 Apr; 8(2):97-104. PubMed ID: 12745659
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
[TBL] [Abstract][Full Text] [Related]
19. Breaking immunotolerance of tumors: a new perspective for dendritic cell therapy.
Rolinski J; Hus I
J Immunotoxicol; 2014 Oct; 11(4):311-8. PubMed ID: 24495309
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
